For citations:
Lomaia E.G., Romanova E.G., Sbityakova E.I., Zaritskiy A.Yu. Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia. Oncohematology. 2013;8(2):22-33. (In Russ.) https://doi.org/10.17650/1818-8346-2013-8-2-22-33
Email this article 